Search | Connect Little

Satakshi Gupta added blog Other
2026-05-18 10:21:55 -

(R)-Nipecotic Acid Ethyl Ester Market Size & Forecast 2034 | Chiral Pharmaceutical Intermediate for CNS Drugs, GABA Uptake Inhibitors & Neurological Therapeutics
Global (R)-Nipecotic acid ethyl ester market was valued at USD 18.6 million in 2025 and is projected to reach USD 34.2 million by 2034, exhibiting a remarkable CAGR of 7.1% during the forecast period. (R)-Nipecotic acid ethyl ester is a specialized chiral pharmaceutical intermediate derived from nipecotic acid, valued for its role as a selective GABA uptake inhibitor. It has transitioned...

0 Comments 0 Shares 138 Views 0 Reviews

Please log in to like, share and comment!
Satakshi Gupta added blog Other
2026-05-18 10:22:05 -

(R)-Nipecotic Acid Ethyl Ester Market Size & Forecast 2034 | Chiral Pharmaceutical Intermediate for CNS Drugs, GABA Uptake Inhibitors & Neurological Therapeutics
Global (R)-Nipecotic acid ethyl ester market was valued at USD 18.6 million in 2025 and is projected to reach USD 34.2 million by 2034, exhibiting a remarkable CAGR of 7.1% during the forecast period. (R)-Nipecotic acid ethyl ester is a specialized chiral pharmaceutical intermediate derived from nipecotic acid, valued for its role as a selective GABA uptake inhibitor. It has transitioned...

0 Comments 0 Shares 116 Views 0 Reviews

Please log in to like, share and comment!
Komal Galande added blog Crafts
2026-01-05 06:24:51 -

Parkinson’s Disease Treatment Market Advances with Novel Therapies and Improved Patient Care
Executive Summary Parkinson’s Disease Treatment Market Size and Share Forecast Data Bridge Market Research analyses that the Parkinson’s disease treatment market which was USD 4,999.18 million in 2022, would rocket up to USD 10,034.52 million by 2030, and is expected to undergo a CAGR of 9.10% during the forecast period. Parkinson’s Disease Treatment Market report...

0 Comments 0 Shares 2K Views 0 Reviews

Please log in to like, share and comment!